查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612802

心臟标记测试市场：按产品、生物标记、测试类型、疾病 - 全球预测 2025-2030

Cardiac Marker Testing Market by Product (Instruments, Reagents & Kits), Biomarker (BNP Or NT-ProBNP, Ceratine Kinase-MB, hs-CRP), Type of Testing, Disease - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年心臟标记检测市场价值为51亿美元，预计2024年将达到55亿美元，复合年增长率为7.90%，预计到2030年将达到86.9亿美元。

心臟标记检测是透过检测血液中的特定生物分子来诊断和治疗心血管疾病（主要是心臟病发作和急性冠状动脉症候群）的重要过程。心臟标记检测的需求源于其在提供有效患者管理和治疗所需的快速、准确诊断方面的作用。此测试在紧急情况下尤其重要，例如对于出现胸痛等症状或可能患有心肌梗塞的患者。心臟标记测试的应用遍及医院、诊所和诊断实验室，主要最终用户是需要及时可靠的资料来做出治疗决策的医疗保健专业人员。

主要市场统计
基准年[2023] 51亿美元
预测年份 [2024] 55亿美元
预测年份 [2030] 86.9亿美元
复合年增长率（%） 7.90%

心臟标记检测市场的成长受到心血管疾病盛行率上升、人口老化和诊断技术进步的显着影响。该领域的显着商机包括就地检验设备的开发和集成，这些设备可以快速提供结果，并且由于其便利性和效率而受到很高的需求。高灵敏度检测系统的出现为技术创新和提高市场渗透率提供了进一步的机会。儘管存在这些机会，但先进测试技术的高成本、监管复杂性和报销问题等挑战正在限制市场成长。此外，市场面临来自替代诊断方法的竞争，这可能会阻碍市场扩张。

创新和研发的机会在于开发多标记测试组，提供全面的心臟概况，并结合人工智慧以更好地预测分析心臟事件的诊断。尖端研究还可以集中于识别新型心臟生物标记物，以提高诊断准确性和预后价值。该市场的特点是技术快速进步和竞争格局激烈，需要持续创新和策略联盟。公司可以透过投资研发、扩大产品系列併采用先进技术来满足医疗保健提供者不断变化的需求，从而实现成长并确保市场相关性和竞争力。

市场动态：揭示快速发展的心臟标记测试市场的关键市场洞察

供需的动态交互作用正在改变心臟标记检测市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 心血管疾病的流行和有效诊断的必要性
    • 全球心臟标记就地检验的兴起
    • 努力鼓励心血管疾病的早期发现和筛检
  • 市场限制因素
    • 心臟标记检测产品的不利召回
  • 市场机会
    • 测试技术的进步和新生物标记的整合
    • 介绍向个人化医疗和客製化心臟标记测试的转变
  • 市场挑战
    • 对心臟标记测试不准确和特异性有限的担忧

波特五力：驾驭心臟标记测试市场的策略工具

波特的五力框架是了解心臟标记测试市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解心臟标记测试市场的外部影响

外部宏观环境因素在塑造心臟标记检测市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解心臟标记检测市场的竞争状况

心臟标记物测试市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵心臟标记测试市场供应商的绩效评估

FPNV定位矩阵是评估心臟标记检测市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製心臟标记测试市场的成功之路

心臟标记测试市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心血管疾病的盛行率和有效诊断的必要性
      • 全球就地检验有所增加
      • 努力促进心血管疾病的早期发现和筛检
    • 抑制因素
      • 心臟标记物测试产品的不良召回
    • 机会
      • 测试技术的进步和新生物标记的整合
      • 介绍向个人化医疗和客製化医疗的转变
    • 任务
      • 对心臟标记测试的不准确性和特异性有限的担忧
  • 市场区隔分析
    • 产品：诊断设备在心臟标记检测中的重要性
    • 生物标记：在心臟评估中增加肌钙蛋白生物标记的使用
    • 测试类型：更多采用就地检验
    • 疾病：心臟标记检测在心肌梗塞的广泛应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章心臟标记测试市场：依产品

  • 装置
    • 化学冷光
    • 酵素连结免疫吸附试验
    • 层析法
    • 萤光
  • 试剂和套件

第七章心臟标记测试市场生物标记物

  • BNP 或 NT-ProBNP
  • 丝氨酸激酶-MB
  • hs-CRP
  • 肌红蛋白
  • 肌钙蛋白

第八章按测试类型分類的心臟标记测试市场

  • 临床检查
  • 就地检验

第九章心臟标记检测市场：依疾病分类

  • 郁血性心臟衰竭
  • 心肌梗塞

第十章 北美和南美心臟标记检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太心臟标记检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲心臟标记检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 迈瑞推出新检测方法，扩大心臟生物标记产品组合
    • NOWDx 和 AeenaDx 宣布合併
    • Pathkind Labs 和罗氏诊断公司合作发布心臟生物标记
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Assure Tech（Hangzhou）Co., Ltd.
  • Atlas Medical GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biomerieux SA
  • Boditech Med Inc.
  • Charles River Laboratories International, Inc.
  • Cleerly, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • HyTest Ltd.
  • Laboratory Corporation of America Holdings
  • LightDeck Diagnostics
  • Merck KGaA
  • Natera, Inc.
  • PerkinElmer Inc.
  • Qiagen NV
  • Quest Diagnostics
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Sekbio
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
Product Code: MRR-034230D3E2E7

The Cardiac Marker Testing Market was valued at USD 5.10 billion in 2023, expected to reach USD 5.50 billion in 2024, and is projected to grow at a CAGR of 7.90%, to USD 8.69 billion by 2030.

Cardiac marker testing is a critical process in diagnosing and managing cardiovascular diseases, primarily heart attacks and acute coronary syndromes, through the detection of specific biomolecules in the blood. The necessity of cardiac marker testing stems from its role in providing rapid, accurate diagnosis necessary for effective patient management and treatment. This testing is crucial in emergency settings, particularly for patients exhibiting symptoms such as chest pain or other potential indications of myocardial infarction. The applications of cardiac marker testing extend to hospitals, clinics, and diagnostic laboratories, with key end-users being healthcare professionals who require timely and reliable data to inform treatment decisions.

KEY MARKET STATISTICS
Base Year [2023] USD 5.10 billion
Estimated Year [2024] USD 5.50 billion
Forecast Year [2030] USD 8.69 billion
CAGR (%) 7.90%

Market growth for cardiac marker testing is significantly influenced by the rising prevalence of cardiovascular diseases, an aging population, and advancements in diagnostic technologies. Notable opportunities in this field include the development and integration of point-of-care testing devices, which offer quick results and are increasingly in demand due to their convenience and efficiency. The advent of high-sensitivity assay systems further presents opportunities for innovation and improved market penetration. Despite these opportunities, challenges such as high cost of advanced testing technologies, regulatory complexities, and reimbursement issues pose limitations to market growth. Additionally, the market faces competition from alternative diagnostic modalities, which might hinder its expansion.

Innovation and research opportunities lie in the development of multi-marker testing panels that provide comprehensive cardiac profiles and the incorporation of artificial intelligence for better predictive analytics in diagnosing cardiac events. Cutting-edge research could also focus on identifying novel cardiac biomarkers that enhance diagnostic accuracy and prognostic value. The nature of the market is characterized by rapid technological advancements and a competitive landscape, necessitating continuous innovation and strategic partnerships. Businesses can achieve growth by investing in R&D, expanding their product portfolios, and adopting technological advancements to meet the evolving needs of healthcare providers, ensuring market relevance and competitiveness.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Marker Testing Market

The Cardiac Marker Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of cardiovascular diseases and need for effective diagnostics
    • Rise of point-of-care testing for cardiac markers worldwide
    • Initiatives encouraging early detection and screening of cardiovascular diseases
  • Market Restraints
    • Adverse recalls of cardiac marker testing products
  • Market Opportunities
    • Advancements in testing technologies and integration of new biomarkers
    • Shift toward personalized medicine and introduction of tailored cardiac marker testing
  • Market Challenges
    • Concerns associated with inaccuracy and limited specificity of cardiac marker testing

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Marker Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Marker Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Marker Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Marker Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Marker Testing Market

A detailed market share analysis in the Cardiac Marker Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Marker Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Marker Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Marker Testing Market

A strategic analysis of the Cardiac Marker Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Marker Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Assure Tech (Hangzhou) Co., Ltd., Atlas Medical GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biomerieux SA, Boditech Med Inc., Charles River Laboratories International, Inc., Cleerly, Inc., Danaher Corporation, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche AG, HyTest Ltd., Laboratory Corporation of America Holdings, LightDeck Diagnostics, Merck KGaA, Natera, Inc., PerkinElmer Inc., Qiagen N.V., Quest Diagnostics, QuidelOrtho Corporation, Randox Laboratories Ltd., Sekbio, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Tosoh Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Marker Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instruments and Reagents & Kits. The Instruments is further studied across Chemiluminescence, ELISA, Immunochromatography, and Immunofluorescence.
  • Based on Biomarker, market is studied across BNP Or NT-ProBNP, Ceratine Kinase-MB, hs-CRP, Myoglobin, and Troponin.
  • Based on Type of Testing, market is studied across Laboratory Testing and Point-Of-Care Testing.
  • Based on Disease, market is studied across Congestive Heart Failure and Myocardial Infarction.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of cardiovascular diseases and need for effective diagnostics
      • 5.1.1.2. Rise of point-of-care testing for cardiac markers worldwide
      • 5.1.1.3. Initiatives encouraging early detection and screening of cardiovascular diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse recalls of cardiac marker testing products
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in testing technologies and integration of new biomarkers
      • 5.1.3.2. Shift toward personalized medicine and introduction of tailored cardiac marker testing
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with inaccuracy and limited specificity of cardiac marker testing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Significance of diagnostic instruments in cardiac marker testing
    • 5.2.2. Biomarker: Rising utilization of Troponin biomarker for cardiac assessment
    • 5.2.3. Type of Testing: Increasing adoption of Point-of-Care testing
    • 5.2.4. Disease: Extensive applications of cardiac marker testing in myocardial infarction
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac Marker Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
    • 6.2.1. Chemiluminescence
    • 6.2.2. ELISA
    • 6.2.3. Immunochromatography
    • 6.2.4. Immunofluorescence
  • 6.3. Reagents & Kits

7. Cardiac Marker Testing Market, by Biomarker

  • 7.1. Introduction
  • 7.2. BNP Or NT-ProBNP
  • 7.3. Ceratine Kinase-MB
  • 7.4. hs-CRP
  • 7.5. Myoglobin
  • 7.6. Troponin

8. Cardiac Marker Testing Market, by Type of Testing

  • 8.1. Introduction
  • 8.2. Laboratory Testing
  • 8.3. Point-Of-Care Testing

9. Cardiac Marker Testing Market, by Disease

  • 9.1. Introduction
  • 9.2. Congestive Heart Failure
  • 9.3. Myocardial Infarction

10. Americas Cardiac Marker Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cardiac Marker Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cardiac Marker Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Mindray Expands Cardiac Biomarker Portfolio with Launch of New Assays
    • 13.3.2. NOWDx and AeenaDx Announce Merger
    • 13.3.3. Pathkind Labs, Roche Diagnostics Partner to Release Cardiac Biomarker
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Assure Tech (Hangzhou) Co., Ltd.
  • 4. Atlas Medical GmbH
  • 5. Becton, Dickinson and Company
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Bio-Techne Corporation
  • 8. Biomerieux SA
  • 9. Boditech Med Inc.
  • 10. Charles River Laboratories International, Inc.
  • 11. Cleerly, Inc.
  • 12. Danaher Corporation
  • 13. DiaSorin S.p.A.
  • 14. Eurofins Scientific SE
  • 15. F. Hoffmann-La Roche AG
  • 16. HyTest Ltd.
  • 17. Laboratory Corporation of America Holdings
  • 18. LightDeck Diagnostics
  • 19. Merck KGaA
  • 20. Natera, Inc.
  • 21. PerkinElmer Inc.
  • 22. Qiagen N.V.
  • 23. Quest Diagnostics
  • 24. QuidelOrtho Corporation
  • 25. Randox Laboratories Ltd.
  • 26. Sekbio
  • 27. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 28. Siemens Healthineers AG
  • 29. Thermo Fisher Scientific Inc.
  • 30. Tosoh Corporation

LIST OF FIGURES

  • FIGURE 1. CARDIAC MARKER TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC MARKER TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CARDIAC MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CARDIAC MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC MARKER TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC MARKER TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BNP OR NT-PROBNP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CERATINE KINASE-MB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HS-CRP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 236. CARDIAC MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 237. CARDIAC MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2023